Skip to main content
Top
Published in: Annals of Surgical Oncology 5/2011

01-05-2011 | Breast Oncology

Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional Review

Authors: Sameer Damle, MD, Christine B. Teal, MD, Joanne J. Lenert, MD, Elizabeth C. Marshall, MD, MPH, Qing Pan, PhD, Anita P. McSwain, MD, MPH

Published in: Annals of Surgical Oncology | Issue 5/2011

Login to get access

Abstract

Background

Breast conservation surgery (BCS) followed by radiation is as effective as mastectomy for long-term survival and is considered standard of care for early-stage breast cancer. An increasing number of patients are opting for cancer-side mastectomies (CM) and often contralateral prophylactic mastectomies (CPM). Our study investigates if there are increasing trends in our patient population toward CM and CPM and identifies common factors associated with those electing to have more extensive surgery.

Methods

A retrospective analysis was performed on 812 breast cancer surgeries between January 2001 and December 2009 at The George Washington University Breast Care Center. BCS-eligible patients who elected to have BCS were compared with those who chose CM. Patients who underwent CM were compared with patients undergoing CM and CPM.

Results

A personal or family history of breast cancer and larger tumor size were positively associated with choosing CM in BCS-eligible patients. A nonstatistically significant trend toward CM was seen in younger patients. Age, family history, fewer children, Caucasian race, and reconstructive surgery were positively associated with choosing CPM.

Conclusion

Mastectomy rates at this institution have not shown the recent sharp increase observed by some authors. The association of age, race, family history, and parity with CPM has been corroborated in multiple studies. However, there is disagreement between statistically significant findings among investigators evaluating factors associated with CPM, and there is limited data in the literature characterizing BCS-eligible patients who chose CM. Larger prospective studies are necessary to further evaluate CM and CPM rates.
Literature
1.
go back to reference NIH Consensus Development Conference statement on the treatment of early-stage breast cancer. J Natl Cancer Inst Monogr. 1992;11:1–5. NIH Consensus Development Conference statement on the treatment of early-stage breast cancer. J Natl Cancer Inst Monogr. 1992;11:1–5.
2.
go back to reference McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.PubMedCrossRef McGuire KP, Santillan AA, Kaur P, Meade T, Parbhoo J, Mathias M, et al. A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16:2682–90.PubMedCrossRef
3.
go back to reference Van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA 2 mutation carriers. Br J Cancer. 2005;93:287–92.PubMedCrossRef Van Sprundel TC, Schmidt MK, Rookus MA, Brohet R, van Asperen CJ, Rutgers EJ, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA 2 mutation carriers. Br J Cancer. 2005;93:287–92.PubMedCrossRef
4.
go back to reference McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938–43.PubMed McDonnell SK, Schaid DJ, Myers JL, Grant CS, Donohue JH, Woods JE, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938–43.PubMed
5.
go back to reference Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for prevention of breast cancer. Cochrane Database Syst Rev. 2004;4:CD002748.PubMed Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for prevention of breast cancer. Cochrane Database Syst Rev. 2004;4:CD002748.PubMed
6.
go back to reference Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102:1–9.CrossRef Bedrosian I, Hu CY, Chang GJ. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst. 2010;102:1–9.CrossRef
7.
go back to reference Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of Surgical Oncology: position statement on prophylactic mastectomy. Ann Surg Oncol. 2007;14:2425–7.PubMedCrossRef Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of Surgical Oncology: position statement on prophylactic mastectomy. Ann Surg Oncol. 2007;14:2425–7.PubMedCrossRef
8.
go back to reference Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 1996;88:1529–42.PubMedCrossRef Fisher B, Dignam J, Bryant J, Wolmark N. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 1996;88:1529–42.PubMedCrossRef
10.
go back to reference Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097–101.PubMedCrossRef Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097–101.PubMedCrossRef
11.
go back to reference McCahill LE, Privette AR, Hart MR, James TA. Are mastectomy rates a reasonable quality measure of breast cancer surgery? Am J Surg. 2009;197:216–21.PubMedCrossRef McCahill LE, Privette AR, Hart MR, James TA. Are mastectomy rates a reasonable quality measure of breast cancer surgery? Am J Surg. 2009;197:216–21.PubMedCrossRef
12.
go back to reference Nold RJ, Beamer RL, Helmer SD, McBoyle MF. Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg. 2000;180:413–8.PubMedCrossRef Nold RJ, Beamer RL, Helmer SD, McBoyle MF. Factors influencing a woman’s choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg. 2000;180:413–8.PubMedCrossRef
13.
go back to reference Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.PubMedCrossRef Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.PubMedCrossRef
14.
go back to reference Crowe JP, Patrick RJ, Rim A. The importance of preoperative breast MRI for patients newly diagnosed with breast cancer. Breast J. 2009;15:52–60.PubMedCrossRef Crowe JP, Patrick RJ, Rim A. The importance of preoperative breast MRI for patients newly diagnosed with breast cancer. Breast J. 2009;15:52–60.PubMedCrossRef
15.
go back to reference Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.PubMedCrossRef Bedrosian I, Mick R, Orel SG, Schnall M, Reynolds C, Spitz FR, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.PubMedCrossRef
16.
go back to reference Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High-resolution scintimammography: a pilot study. J Nucl Med. 2007;43:909–15. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High-resolution scintimammography: a pilot study. J Nucl Med. 2007;43:909–15.
17.
go back to reference Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:188–94.PubMedCrossRef Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:188–94.PubMedCrossRef
18.
go back to reference Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol. 1998;9:1179–84.PubMedCrossRef Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, et al. A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol. 1998;9:1179–84.PubMedCrossRef
19.
go back to reference Chagpar AB, Studts JL, Scoggins CR, Martin RC II, Carlson DJ, Laidley AL, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106;1462–6.PubMedCrossRef Chagpar AB, Studts JL, Scoggins CR, Martin RC II, Carlson DJ, Laidley AL, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106;1462–6.PubMedCrossRef
20.
go back to reference Wang J, Kollias J, Boult M, Babidge W, Zorbas HN, Roder D, et al. Patterns of surgical treatment for women with breast cancer in relation to age. Breast J. 2010;16:60–5.PubMedCrossRef Wang J, Kollias J, Boult M, Babidge W, Zorbas HN, Roder D, et al. Patterns of surgical treatment for women with breast cancer in relation to age. Breast J. 2010;16:60–5.PubMedCrossRef
21.
go back to reference Lee MC, Rogers K, Griffith K, Diehl KA, Breslin TM, Cimmino VM, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15:34–40.PubMedCrossRef Lee MC, Rogers K, Griffith K, Diehl KA, Breslin TM, Cimmino VM, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15:34–40.PubMedCrossRef
22.
go back to reference Moreland A, Zhang Y, Dissanaike S, Arya R. Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer. Am J Surg. 2009;198:787–91.PubMedCrossRef Moreland A, Zhang Y, Dissanaike S, Arya R. Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer. Am J Surg. 2009;198:787–91.PubMedCrossRef
25.
go back to reference Albain KS, Green SR, Lichter AS, Hutchins LF, Wood WC, Henderson IC, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996;14:3009–17.PubMed Albain KS, Green SR, Lichter AS, Hutchins LF, Wood WC, Henderson IC, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996;14:3009–17.PubMed
26.
go back to reference Verkooijen HM, Rapiti E, Fioretta G, Vinh-Hung V, Keller J, Benhamou S, et al. Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups. Cancer Causes Control. 2009;20:1689–96.PubMedCrossRef Verkooijen HM, Rapiti E, Fioretta G, Vinh-Hung V, Keller J, Benhamou S, et al. Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups. Cancer Causes Control. 2009;20:1689–96.PubMedCrossRef
28.
go back to reference Malata CM, McIntosh SA, Purushotham AD. Immediate breast reconstruction after mastectomy for cancer. Br J Surg. 2000;87:1455–72.PubMedCrossRef Malata CM, McIntosh SA, Purushotham AD. Immediate breast reconstruction after mastectomy for cancer. Br J Surg. 2000;87:1455–72.PubMedCrossRef
29.
go back to reference Alderman AK, Hawley ST, Waljee J, Morrow M, Katz SJ. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer. 2007;109:1715–20.PubMedCrossRef Alderman AK, Hawley ST, Waljee J, Morrow M, Katz SJ. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer. 2007;109:1715–20.PubMedCrossRef
30.
go back to reference Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.PubMedCrossRef Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.PubMedCrossRef
31.
go back to reference Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical management. J Clin Oncol. 2007;25:5203–9.PubMedCrossRef Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical management. J Clin Oncol. 2007;25:5203–9.PubMedCrossRef
32.
go back to reference Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–7.PubMedCrossRef Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181–7.PubMedCrossRef
33.
go back to reference Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180:439–45.PubMedCrossRef Peralta EA, Ellenhorn JD, Wagman LD, Dagis A, Andersen JS, Chu DZ. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg. 2000;180:439–45.PubMedCrossRef
34.
go back to reference Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol. 2008;26:1093–7.PubMedCrossRef Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the hereditary breast cancer clinical study group. J Clin Oncol. 2008;26:1093–7.PubMedCrossRef
Metadata
Title
Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional Review
Authors
Sameer Damle, MD
Christine B. Teal, MD
Joanne J. Lenert, MD
Elizabeth C. Marshall, MD, MPH
Qing Pan, PhD
Anita P. McSwain, MD, MPH
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 5/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1434-0

Other articles of this Issue 5/2011

Annals of Surgical Oncology 5/2011 Go to the issue